Heterogeneity of hepatitis C virus genotypes in hemophilia: relationship with chronic liver disease.

In this study we have determined the hepatitis C virus (HCV) serotype and genotype in a cohort of 96 HCV-infected hemophiliacs and have examined the relationship between HCV genotype and severity of chronic liver disease as determined by liver biopsy. HCV serotype was determined by specific enzyme-linked immunosorbent assays (ELISAs) and genotype by restriction fragment length polymorphism (RFLP) and HCV viral sequencing. The pattern of genotype distribution was quite unlike that of HCV-infected United Kingdom (UK) blood donors in that five of the six known HCV genotypes were represented, 50% were type 1, 13% type 2, and 18% type 3. An unexpected observation was the presence of HCV genotype 4 in four patients and type 5 in two patients. An additional feature was the presence of mixed infection, detected in 14% and 7% by serotype and genotype analysis, respectively. Liver biopsies were available from 51 patients. Cirrhosis was present in five of 27 (19%) of individuals with type 1, in 2 of 9 (22%) with type 2, and 5 of 8 (63%) of those with type 3. The heterogeneous pattern of HCV genotype distribution in this cohort of patients and the observed relationship between the severity of the related liver disease and specific HCV genotype may have important implications with respect to the natural history and treatment of HCV-related chronic liver disease in infected hemophiliacs worldwide.

[1]  A. Keller,et al.  Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey , 1994, Journal of clinical microbiology.

[2]  W. Quint,et al.  Sequence analysis of the 5' untranslated region in isolates of at least four genotypes of hepatitis C virus in The Netherlands , 1994, Journal of clinical microbiology.

[3]  S Sherlock,et al.  Hepatitis C virus genotypes: An investigation of type‐specific differences in geographic origin and disease , 1994, Hepatology.

[4]  J. Villeneuve,et al.  Sequence Analysis of the 5′ Noncoding Region Reveals the Existence of Multiple Hepatitis C Virus Genotypes in Quebec, Canada , 1994 .

[5]  E. Holmes,et al.  Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. , 1993, The Journal of general virology.

[6]  R H Purcell,et al.  At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Simmonds,et al.  Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3 , 1993, Journal of clinical microbiology.

[8]  R. Tedder,et al.  Hepatitis C viral RNA in clotting factor concentrates and the development of hepatitis in recipients. , 1993, Blood.

[9]  E. Holmes,et al.  Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. , 1993, The Journal of general virology.

[10]  P. Simmonds,et al.  Detection of three types of hepatitis C virus in blood donors: investigation of type‐specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities , 1993, Transfusion.

[11]  Motohiro Shibata,et al.  Detection of hepatitis C virus by polymerase chain reaction and response to interferon‐α therapy: Relationship to genotypes of hepatitis C virus , 1992, Hepatology.

[12]  B. Irvine,et al.  At least five related, but distinct, hepatitis C viral genotypes exist. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  R. Purcell,et al.  Sequence analysis of the 5' noncoding region of hepatitis C virus. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Mishiro,et al.  Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. , 1992, Virology.

[15]  E. Holmes,et al.  Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. , 1992, The Journal of general virology.

[16]  P. Simmonds,et al.  Use of several second generation serological assays to determine the true prevalence of hepatitis C virus infection in haemophiliacs treated with non‐virus inactivated factor VIII and IX concentrates , 1992, British journal of haematology.

[17]  N. Kato,et al.  A new type of hepatitis C virus in patients in Thailand. , 1992, Biochemical and biophysical research communications.

[18]  T. Ishikawa,et al.  Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. , 1992, Hepatology.

[19]  S. Kaneko,et al.  Severity of liver disease with different hepatitis C viral clones , 1991, The Lancet.

[20]  P. Karayiannis,et al.  High risk of non‐A non‐B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin , 1985, British journal of haematology.

[21]  C. Rizza,et al.  Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients. , 1983, British medical journal.

[22]  U. Hasiba,et al.  Chronic Liver Dysfunction in Multitransfused Hemophiliacs , 1977, Transfusion.

[23]  C. Kasper,et al.  Hepatitis and clotting-factor concentrates. , 1972, JAMA.